Literature DB >> 25237102

Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal.

Iman Fares1, Jalila Chagraoui1, Yves Gareau2, Stéphane Gingras2, Réjean Ruel2, Nadine Mayotte1, Elizabeth Csaszar3, David J H F Knapp4, Paul Miller4, Mor Ngom4, Suzan Imren4, Denis-Claude Roy5, Kori L Watts6, Hans-Peter Kiem7, Robert Herrington8, Norman N Iscove9, R Keith Humphries4, Connie J Eaves4, Sandra Cohen5, Anne Marinier2, Peter W Zandstra3, Guy Sauvageau10.   

Abstract

The small number of hematopoietic stem and progenitor cells in cord blood units limits their widespread use in human transplant protocols. We identified a family of chemically related small molecules that stimulates the expansion ex vivo of human cord blood cells capable of reconstituting human hematopoiesis for at least 6 months in immunocompromised mice. The potent activity of these newly identified compounds, UM171 being the prototype, is independent of suppression of the aryl hydrocarbon receptor, which targets cells with more-limited regenerative potential. The properties of UM171 make it a potential candidate for hematopoietic stem cell transplantation and gene therapy.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25237102      PMCID: PMC4372335          DOI: 10.1126/science.1256337

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling.

Authors:  Elizabeth Csaszar; Daniel C Kirouac; Mei Yu; WeiJia Wang; Wenlian Qiao; Michael P Cooke; Anthony E Boitano; Caryn Ito; Peter W Zandstra
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.

Authors:  Alejandro B Balazs; Attila J Fabian; Charles T Esmon; Richard C Mulligan
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

3.  Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs.

Authors:  Claudia Benz; Michael R Copley; David G Kent; Stefan Wohrer; Adrian Cortes; Nima Aghaeepour; Elaine Ma; Heidi Mader; Keegan Rowe; Christopher Day; David Treloar; Ryan R Brinkman; Connie J Eaves
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia.

Authors:  Ivan Sloma; Philip A Beer; Kyi Min Saw; Matthew Chan; Donna Leung; Kamini Raghuram; Cedric Brimacombe; Bobby Johnston; Karen Lambie; Donna Forrest; Xiaoyan Jiang; Connie J Eaves
Journal:  Exp Hematol       Date:  2013-07-11       Impact factor: 3.084

5.  Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.

Authors:  E C Henry; A S Kende; G Rucci; M J Totleben; J J Willey; S D Dertinger; R S Pollenz; J P Jones; T A Gasiewicz
Journal:  Mol Pharmacol       Date:  1999-04       Impact factor: 4.436

6.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

7.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

8.  Long-term propagation of distinct hematopoietic differentiation programs in vivo.

Authors:  Brad Dykstra; David Kent; Michelle Bowie; Lindsay McCaffrey; Melisa Hamilton; Kristin Lyons; Shang-Jung Lee; Ryan Brinkman; Connie Eaves
Journal:  Cell Stem Cell       Date:  2007-08-16       Impact factor: 24.633

9.  Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice.

Authors:  Alice M S Cheung; Long V Nguyen; Annaick Carles; Philip Beer; Paul H Miller; David J H F Knapp; Kiran Dhillon; Martin Hirst; Connie J Eaves
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

Review 10.  Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?

Authors:  M Norkin; H M Lazarus; J R Wingard
Journal:  Bone Marrow Transplant       Date:  2012-09-03       Impact factor: 5.483

View more
  195 in total

Review 1.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Patching up hematopoietic stem cells.

Authors:  Giorgia Santilli; Adrian J Thrasher
Journal:  Nat Biotechnol       Date:  2015-12-09       Impact factor: 54.908

3.  Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.

Authors:  Jennifer L Gori; Jason M Butler; Yan-Yi Chan; Devikha Chandrasekaran; Michael G Poulos; Michael Ginsberg; Daniel J Nolan; Olivier Elemento; Brent L Wood; Jennifer E Adair; Shahin Rafii; Hans-Peter Kiem
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

4.  Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment.

Authors:  Bin Guo; Xinxin Huang; Scott Cooper; Hal E Broxmeyer
Journal:  Nat Med       Date:  2017-03-06       Impact factor: 53.440

5.  Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465).

Authors:  Hiro Tatetsu; Myriam Armant; Fei Wang; Chong Gao; Shikiko Ueno; Xi Tian; Alex Federation; Jun Qi; James Bradner; Daniel G Tenen; Li Chai
Journal:  Exp Hematol       Date:  2019-06-28       Impact factor: 3.084

6.  Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.

Authors:  Michael G Daniel; David Sachs; Jeffrey M Bernitz; Yesai Fstkchyan; Katrina Rapp; Namita Satija; Kenneth Law; Foram Patel; Andreia M Gomes; Huen-Suk Kim; Carlos-Filipe Pereira; Benjamin Chen; Ihor R Lemischka; Kateri A Moore
Journal:  FEBS Lett       Date:  2019-10-12       Impact factor: 4.124

Review 7.  Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.

Authors:  Jungmin Lee; Brad Dykstra; Robert Sackstein; Derrick J Rossi
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 8.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 9.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

10.  Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.

Authors:  Dejene M Tufa; Ashley M Yingst; George Devon Trahan; Tyler Shank; Dallas Jones; Seonhui Shim; Jessica Lake; Kevin Winkler; Laura Cobb; Renee Woods; Kenneth Jones; Michael R Verneris
Journal:  Sci Immunol       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.